captopril has been researched along with Glioma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ergul, M; Sahin, B | 1 |
| Hu, Y; Jiang, T; Jiang, X; Jin, K; Luo, Z; Mei, H; Pang, Z; Shi, W; Tuo, Y; Zhang, B | 1 |
| Bolle, N; Fish, R; Kruithof, E; Pernod, G; Polack, B; Simard, B; Solly, F | 1 |
| Kandanearatachi, A; Pilkington, GJ; Rooprai, HK; Rucklidge, G | 1 |
| Sakurada, C; Tao, Z; Yokosawa, H | 1 |
5 other study(ies) available for captopril and Glioma
| Article | Year |
|---|---|
Captopril exhibits protective effects through anti-inflammatory and anti-apoptotic pathways against hydrogen peroxide-induced oxidative stress in C6 glioma cells.
Topics: Anti-Inflammatory Agents; Apoptosis Regulatory Proteins; Captopril; Glioma; Humans; Hydrogen Peroxide; Inflammation; Oxidative Stress | 2022 |
Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
Topics: Animals; Antineoplastic Agents; Bradykinin; Brain Neoplasms; Capillary Permeability; Captopril; Cell Line, Tumor; Drug Delivery Systems; Endothelium, Vascular; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Paclitaxel; Regional Blood Flow; Time Factors; Tumor Burden; Vasodilator Agents; Xenograft Model Antitumor Assays | 2017 |
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
Topics: Angiostatins; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Cell Line, Tumor; Combined Modality Therapy; Genetic Therapy; Genetic Vectors; Glioma; Immunohistochemistry; Lentivirus; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Tissue Plasminogen Activator; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro.
Topics: Antineoplastic Agents; Brain Neoplasms; Captopril; Collagenases; Flavones; Flavonoids; Gelatinases; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Neoplasm Invasiveness; Swainsonine; Tumor Cells, Cultured | 1999 |
Evidence for thiol-dependent metallo-endopeptidase involved in degradation of luteinizing hormone-releasing hormone in glioma cells.
Topics: Amino Acid Sequence; Animals; Captopril; Cell Membrane; Chromatography, High Pressure Liquid; Glioma; Gonadotropin-Releasing Hormone; Metalloendopeptidases; Molecular Sequence Data; Molecular Weight; Peptide Fragments; Rats; Sulfhydryl Compounds; Tumor Cells, Cultured | 1991 |